The European Commission is hosting an online event titled "Implementation of the Hospital Exemption in the EU and its role in boosting innovation and patient access to innovative therapies" on 21 November 2024 from 9:00 to 17:00 CET. This event is part of a study conducted by Intellera consulting, Cecoforma, PredictBy, and Empirica, aimed at addressing knowledge gaps regarding the Hospital Exemption in EU Member States. It will gather experts and representatives from academia, the biotech industry, professional organizations, and national authorities to discuss the impact of the Hospital Exemption pathway on patient access to Advanced Therapy Medicinal Products (ATMPs).